1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Any age Sponsor: NCI Protocol IDs: NCI-2011-01997, ANBL0931, U10CA098543, COG-ANBL0931, NCT01041638
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: under 21 Sponsor: NCI Protocol IDs: POG-9347
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: NCI-2012-01527, 0935, CDR0000063533, COG-A0935A, CCG-0935, CCG-0935A, NCT00005576
|
|
4.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-9391, NCI-B94-0002, B94-0002
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: UAB-185, NCI-B89-0005, B89-0005
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: WCCC-CO-9097, NCI-B90-0014, B90-0014
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 to physiologic 70 Sponsor: Protocol IDs: MDA-DM-90102, NCI-B93-0009, B93-0009
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-93049A4, NCI-B93-0001, B93-0001
|
|
9.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 15 and under Sponsor: NCI Protocol IDs: NCI-2011-02975, CHP1002, CDR0000701215, 9122, NCT01418495
|